Beneficial effects of romosozumab on bone mineral density and trabecular bone score assessed by dual-energy X-ray absorptiometry in a family with osteogenesis imperfecta

Osteoporos Int. 2024 May 8. doi: 10.1007/s00198-024-07089-2. Online ahead of print.

Toru Kusakabe¹, Yuki Ishihara^{2

3}, Takuya Kitamura^{2

3}, Akihiro Yasoda⁴, Kazutaka Nanba^{2

3}, Mika Tsuiki^{3

4}, Noriko Satoh-Asahara², Tetsuya Tagami^{2

3}

¹ Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan. kusakabe@kuhp.kyoto-u.ac.jp.
² Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan.
³ Department of Endocrinology and Metabolism, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan.
⁴ Clinical Research Institute, National Hospital Organization (NHO) Kyoto Medical Center, Kyoto, Japan.

No abstract available

Publication types